Bausch + Lomb Corporation (BLCO) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
BLCO Revenue Growth
Revenue Breakdown (FY 2025)
BLCO's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
BLCO Revenue Analysis (2019–2025)
As of May 8, 2026, Bausch + Lomb Corporation (BLCO) generated trailing twelve-month (TTM) revenue of $5.21 billion, reflecting solid growth of +9.4% year-over-year. The most recent quarter (Q1 2026) recorded $1.24 billion in revenue, down 11.5% sequentially.
Looking at the longer-term picture, BLCO's 5-year compound annual growth rate (CAGR) stands at +8.4%, indicating steady revenue expansion. The company achieved its highest annual revenue of $5.10 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows BLCO's business is primarily driven by Device Products (38%), Over the Counter Products (36%), and Pharmaceutical Products (21%).
When compared to Healthcare sector peers including HSIC (+4.0% YoY), ATRC (+15.0% YoY), and LNTH (+0.6% YoY), BLCO has underperformed the peer group in terms of revenue growth. Compare BLCO vs HSIC →
BLCO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BLCOCurrent | $5.2B | +9.4% | +8.4% | 3.7% | |
 HSIC | $13.2B | +4.0% | +5.4% | 5.7% | |
 ATRC | $535M | +15.0% | +20.9% | -0.6% | |
 LNTH | $1.5B | +0.6% | +35.3% | 20.2% | |
 JNJ | $88.8B | +3.7% | +1.6% | 24.9% | |
 ABT | $42.0B | +6.4% | +5.6% | 16.3% |
BLCO Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $5.10B | +6.5% | $2.79B | 54.8% | $188.0M | 3.7% |
| 2024 | $4.79B | +15.6% | $2.92B | 60.9% | $162.0M | 3.4% |
| 2023 | $4.15B | +10.0% | $2.50B | 60.4% | $130.0M | 3.1% |
| 2022 | $3.77B | +0.1% | $2.25B | 59.7% | $207.0M | 5.5% |
| 2021 | $3.77B | +10.3% | $2.30B | 61.0% | $329.0M | 8.7% |
| 2020 | $3.41B | -9.7% | $2.13B | 62.3% | $260.0M | 7.6% |
| 2019 | $3.78B | - | $2.45B | 64.9% | $396.0M | 10.5% |
See BLCO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BLCO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BLCO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBLCO — Frequently Asked Questions
Quick answers to the most common questions about buying BLCO stock.
Is BLCO's revenue growth accelerating or slowing?
BLCO maintains +9.4% revenue growth, in line with its 5-year CAGR of +8.4%. TTM revenue stands at $5.2B. Growth rate remains consistent with historical average.
What is BLCO's long-term revenue growth rate?
Bausch + Lomb Corporation's 5-year revenue CAGR of +8.4% reflects the sustained expansion pattern. Current YoY growth of +9.4% is near this long-term average.
How is BLCO's revenue distributed by segment?
BLCO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.